Searching News Database: PDL BioPharma
HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
HSMN NewsFeed - 21 Mar 2017
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
HSMN NewsFeed - 9 Jan 2017
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
HSMN NewsFeed - 2 Jun 2016
ARIAD Completes the Sale of Its European Operations and Out-License of European Rights to Iclusig(R)
ARIAD Completes the Sale of Its European Operations and Out-License of European Rights to Iclusig(R)
HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
HSMN NewsFeed - 10 Jul 2014
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
HSMN NewsFeed - 18 Jun 2014
Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer
Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer
HSMN NewsFeed - 3 Feb 2014
PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration
PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration
HSMN NewsFeed - 24 Jul 2013
PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
HSMN NewsFeed - 13 Jun 2012
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
HSMN NewsFeed - 17 Feb 2012
Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer
Threshold Pharmaceuticals Appoints Dr. Tillman Pearce as Chief Medical Officer
HSMN NewsFeed - 16 Nov 2010
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed - 19 Oct 2009
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
HSMN NewsFeed - 9 Jul 2009
Facet Biotech Appoints Mark Rolfe, Ph.D. as Senior Vice President and Chief Scientific Officer
Facet Biotech Appoints Mark Rolfe, Ph.D. as Senior Vice President and Chief Scientific Officer
HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
HSMN NewsFeed - 1 Aug 2008
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V.
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V.
HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
HSMN NewsFeed - 9 Apr 2007
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
HSMN NewsFeed - 21 Feb 2007
OncoMed Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer
OncoMed Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 22 Jan 2007
Cytokinetics Announces Changes to its Executive Management Team and Board of Directors
Cytokinetics Announces Changes to its Executive Management Team and Board of Directors
HSMN NewsFeed - 30 Aug 2006
PDL BioPharma Announces Roche Discontinuation of Co-Development of Daclizumab in Asthma
PDL BioPharma Announces Roche Discontinuation of Co-Development of Daclizumab in Asthma
HSMN NewsFeed - 7 Mar 2006
PDL BioPharma Names Andrew Guggenhime Senior Vice President and Chief Financial Officer
PDL BioPharma Names Andrew Guggenhime Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 6 Mar 2006
West Coast Biologicals, Inc. Announces Appointment of Mark Backer, Ph.D. as President and CEO
West Coast Biologicals, Inc. Announces Appointment of Mark Backer, Ph.D. as President and CEO
